AIDS Alert Archives – July 1, 2004
July 1, 2004
View Archives Issues
-
New York City group leads the way toward a more optimistic future for ASOs
Many AIDS service organizations (ASOs) and tax-funded HIV/AIDS prevention programs have struggled in recent years with budget cutbacks, new grant and oversight requirements, and program censorship either overt or subtle. -
Making money the old-fashioned way
For those who doubt that a large AIDS service organization (ASO) can succeed financially without big private or government grants, Housing Works is an example of how it can be done. -
One-stop shopping for client needs
Housing Works Inc. of New York City fulfills a major part of its mission through three health care facilities that provide a wide variety of health care services. In addition to its primary care and mental health care for HIV/AIDS patients, the organization has developed some subspecialties and soon will expand these, says Errol A. Chin-Loy, senior vice president for health services. -
Myriad needs addressed under one huge umbrella
HIV/AIDS clients who seek help from Housing Works Inc. of New York City will find themselves enrolled in a holistic program that addresses personal and social needs, as well as their medical care. -
HIV-STD synergy worries public health officials
There is little good news about sexually transmitted diseases (STDs) and sexual risk-taking behavior in the United States, and this continues to worry public health officials and HIV researchers. Syphilis infection rates continue to increase in the United States for the third straight year, particularly among men who have sex with men (MSM). Other data show STD rates are high especially among MSM who use illegal drugs, such as crystal methamphetamine, and are even higher among MSM who combine crystal meth with sildenafil citrate (Viagra). -
Drugs in four countries meet U.S. standards
Antiretroviral drugs from four developing countries have been found to meet United States Pharmacopoeia (USP) standards for the active drug amount listed on the label, according to a study in the May 1 Clinical Infectious Diseases.